deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT04614584

Mirtazapine and Methamphetamine Drug-drug Interaction Study

Phase 1 Safety-interaction Study of Mirtazapine for the Treatment of Methamphetamine Use Disorder

Sponsor: San Francisco Department of Public Health

Conditions Cardiovascular Abnormalities Drug Interaction Methamphetamine Use Disorder
Interventions Methamphetamine Mirtazapine
Updated 7 times since 2020 Last updated: Sep 25, 2024 Started: May 3, 2021 Primary completion: May 31, 2024 Completion: May 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04614584, this PHASE1 trial focuses on Cardiovascular Abnormalities and Drug Interaction and remains completed. Sponsored by San Francisco Department of Public Health, it has been updated 7 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotNot Yet Recruiting~Sep 2021 – ~Dec 2023 · 27 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotRecruiting~Oct 2024 – present · 21 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Oct 2024 — Present [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  2. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  4. Dec 2023 — Jul 2024 [monthly]

    Recruiting PHASE1

  5. Sep 2021 — Dec 2023 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE1

  2. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • San Francisco Department of Public Health
  • University of California, Los Angeles
Data source: San Francisco Department of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations